Lv1
56 积分 2023-08-27 加入
KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS
18天前
已完结
Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of Lupus Nephritis
24天前
已完结
Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality
24天前
已完结
KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV)
24天前
已完结
GFR Decline as an Alternative End Point to Kidney Failure in Clinical Trials: A Meta-analysis of Treatment Effects From 37 Randomized Trials
24天前
已完结
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis
2个月前
已完结
Pathogenesis of antimicrobial peptides LL-37 and CpG-ODN in ANCA associated vasculitis
3个月前
已完结
Plasma levels of soluble interleukin 2 receptor, soluble CD30, interleukin 10 and B cell activator of the tumour necrosis factor family during follow-up in vasculitis associated with proteinase 3-antineutrophil cytoplasmic antibodies: associations with disease activity and relapse
4个月前
已完结
Clinical impact of urinary CD11b and CD163 on the renal outcomes of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis
4个月前
已完结
Clinicopathological analysis of MPO-ANCA glomerulonephritis in children on immune cell infiltrates
4个月前
已完结
皖公网安备34019202002308
